Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

HAJEK

Showing results (1481-1490 of 1,751) with videos related to

Pageof 176
Sort By:
Journal of Applied Biomedicine|September 30, 2025
Epidemiology of late postoperative bleeding in OSA-related tonsil surgery: a multicentric retrospective studyJan Vodicka, Martin Chovanec, Milan Urik, et al.
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
Leukemia|July 25, 2018
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasiasMaria Gavriatopoulou, Pellegrino Musto, Jo Caers, et al.
The Lancet. Oncology|August 28, 2017
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trialMeletios A Dimopoulos, Hartmut Goldschmidt, Ruben Niesvizky, et al.
Progress in Cardiovascular Diseases|August 11, 2022
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosisMahmoud Al Rifai, Jie Yao, Xiuqing Guo, et al.
Haematologica|December 3, 2011
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trialMartin Kropff, Honorata Giongco Baylon, Jens Hillengass, et al.
Nature Medicine|May 16, 2022
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trialPeter Hajek, Dunja Przulj, Francesca Pesola, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|April 3, 2024
Social Activities and Risk of Dementia in Community-Dwelling Older People: Gender-Specific Findings From a Prospective Cohort StudyHtet Lin Htun, Achamyeleh Birhanu Teshale, Alice J Owen, et al.
Health Technology Assessment (Winchester, England)|October 16, 2023
Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapyDunja Przulj, Francesca Pesola, Katie Myers Smith, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34<sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
Pageof 176

Showing results (1481-1490 of 1,751) with videos related to

Sort By:
Pageof 176
Journal of Applied Biomedicine|September 30, 2025
Epidemiology of late postoperative bleeding in OSA-related tonsil surgery: a multicentric retrospective studyJan Vodicka, Martin Chovanec, Milan Urik, et al.
Trials|May 27, 2010
Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial)Petr Ostadal, David Alan, Jiri Vejvoda, et al.
Leukemia|July 25, 2018
European myeloma network recommendations on diagnosis and management of patients with rare plasma cell dyscrasiasMaria Gavriatopoulou, Pellegrino Musto, Jo Caers, et al.
The Lancet. Oncology|August 28, 2017
Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trialMeletios A Dimopoulos, Hartmut Goldschmidt, Ruben Niesvizky, et al.
Progress in Cardiovascular Diseases|August 11, 2022
Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosisMahmoud Al Rifai, Jie Yao, Xiuqing Guo, et al.
Haematologica|December 3, 2011
Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: results from OPTIMUM, a randomized trialMartin Kropff, Honorata Giongco Baylon, Jens Hillengass, et al.
Nature Medicine|May 16, 2022
Electronic cigarettes versus nicotine patches for smoking cessation in pregnancy: a randomized controlled trialPeter Hajek, Dunja Przulj, Francesca Pesola, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences|April 3, 2024
Social Activities and Risk of Dementia in Community-Dwelling Older People: Gender-Specific Findings From a Prospective Cohort StudyHtet Lin Htun, Achamyeleh Birhanu Teshale, Alice J Owen, et al.
Health Technology Assessment (Winchester, England)|October 16, 2023
Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes versus nicotine replacement therapyDunja Przulj, Francesca Pesola, Katie Myers Smith, et al.
British Journal of Haematology|October 9, 2023
Insight into the mechanism of CD34<sup>+</sup> cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapyOndrej Venglar, Veronika Kapustova, Anjana Anilkumar Sithara, et al.
Pageof 176